FindTrial
Sign In

A smartphone-based chatbot programme to increase influenze and COVID-19 vaccine uptake among South Asians

Effects of smartphone-based chatbot intervention to increase influenza and COVID-19 vaccine uptake among South Asians: a wait-list randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061503
Enrollment
Unknown
Registered
2022-06-27
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza and COVID-19 vaccine uptake

Interventions

Intervention:Smart-phone based Chatbot Programme

Sponsors

The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. South Asians (from Pakistan, India or Nepal); 2. Aged 18 or older; 3. Unvaccinated for influenza or COVID-19 in the past year; 4. Able to communicate with English, Hindi, Nepali or Hindi and read English, Urdu and Nepali; 5. Have a smartphone.

Exclusion criteria

Exclusion criteria: 1. Participated in any intervention related to influenza and COVID-19 in the past year; 2. Known vaccine contraindications (e.g. a history of severe hypersensitivity to any vaccine component or previous dose of influenza vaccine).

Design outcomes

Primary

MeasureTime frame
Socio-Demographics of the subjectss;Vaccination uptake;—

Countries

China

Contacts

Public ContactDr Wong, Cho Lee

The Chinese University of Hong Kong

jojowong@cuhk.edu.hk+852 3943 8166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026